Recall: D-0218-2017

Class I - Dangerous

Class IClassification

2016-08-04Initiated

OngoingStatus

Hospira Inc., A Pfizer CompanyFirm

Product

Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02

Reason

Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.

Distribution

Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.